VJB-10552-99189
4 vaccinations
9 coded responses
47 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 076 / NJ
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-12
Dose 1 — Pfizer-BioNTech
-
2021-04-16
Registered in v-safe
-
2021-04-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-17
Survey response — days 1–6 daily, dose 1MedDRA: Ocular hyperaemia — Feeling: Good · Fatigue or tirednessFree text: Red eyesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-18
Survey response — days 1–6 daily, dose 1MedDRA: Ocular hyperaemia — Feeling: Good · Fatigue or tirednessFree text: Red blood shot eyeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Survey response — day 7, dose 1MedDRA: Ocular hyperaemia — Feeling: Good · Fatigue or tirednessFree text: Red eyeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-26
-
2021-05-03
Survey response — day 21, dose 1MedDRA: Fatigue — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Report sent to call center — day 21, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-09
Dose 2 — Pfizer-BioNTech
-
2021-05-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to workAdult check-in
-
2021-05-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-05-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-05-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-16
Health check-in — day 7, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-23
- 2021-05-30
-
2021-06-07
Survey response — day 28, dose 2MedDRA: Migraine — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: MigraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-07
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-13
- 2021-06-20
- 2021-08-08
- 2021-09-04
- 2021-09-13
- 2021-11-07
-
2021-12-15
Dose 3 — Pfizer-BioNTech
- 2021-12-15
-
2021-12-16
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-17
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-19
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, Abdominal painAdult check-in
-
2021-12-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-22
- 2021-12-29
- 2022-01-07
- 2022-01-12
- 2022-01-21
- 2022-01-26
- 2022-03-16
-
2022-06-15
Survey response — 6 months, dose 3MedDRA: Large intestine polyp, Vitamin D decreased — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Low Vitamin D levels, and colon polypsMedDRA releases: 2024-11 · check-in free text available
-
2022-06-15
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-16
- 2022-06-16
- 2022-06-16
-
2022-12-14
Dose 4 — Pfizer-BioNTech
- 2022-12-14
-
2022-12-15
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Redness · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-12-16
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-12-17
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-12-18
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-12-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2022-12-21
- 2022-12-28
- 2023-01-04
- 2023-01-12
-
2023-01-18
Survey response — day 35, dose 4MedDRA: Fatigue, Oropharyngeal pain — Feeling: FairMedDRA releases: 2024-11
- 2023-01-25
-
2023-03-16
Survey response — 3 months, dose 4MedDRA: Arthralgia — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-06-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Pfizer-BioNTech | |
| 2 | 2021-05-09 | Pfizer-BioNTech | |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
| 4 | 2022-12-14 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-03 | Unsuccessful | |
| 2021-06-07 | Unsuccessful | |
| 2022-06-15 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Red eyes
Systemic reaction (other): Red blood shot eye
Release 7 — day 7, dose 1
Systemic reaction (other): Red eye
Release 8 — day 21, dose 1
Symptoms: Fatigue
Release 8 — day 28, dose 2
Symptoms: Migraine
Release 12 — 6 months, dose 3
Symptoms: Low Vitamin D levels, and colon polyps
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Large intestine polyp | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Vitamin D decreased | · | · | ✓ |
| SRO | Ocular hyperaemia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release